Navigation Links
Goodwin Biotechnology Inc. and Macrocyclics Announce Collaboration
Date:2/10/2010

PLANTATION, Fla. and DALLAS, Feb. 10 /PRNewswire/ -- Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation.  The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.

"Clinical development programs in nuclear medicine with biotargeted agents require combining chelation chemistry and bioconjugation chemistry to create a product," said Garry E. Kiefer, Ph.D., Chief Executive Officer at Macrocyclics.   "In Goodwin Bio, we found a perfect collaborator to jointly advance diagnostic and therapeutic medicine."

"We are excited about collaborating with Macrocyclics, a company dedicated to the leading-edge development of new chelation chemistry platforms," said Muctarr Sesay, Ph.D., Vice President of Process Development at Goodwin Bio.  "Our integrated cGMP services combined with Macrocyclics' chelation expertise will enhance clinical development programs in nuclear medicine."

About Goodwin Biotechnology, Inc.

Goodwin Bio, (GBI) located in Plantation, FL., is a full service contract biomanufacturing company and specializes in process development and cGMP production of protein based therapeutics for pre-clinical and early phase clinical trials. The products manufactured by Goodwin Bio are being used in clinical trials and the Company has assisted in the preparation of several IND filings for various clients.  GBI caters small to midsize biotech companies, universities, cancer research institutes and various branches of the U.S. Government
'/>"/>

SOURCE Goodwin Biotechnology Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
7. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 A ... accelerated partial breast irradiation (APBI) via interstitial brachytherapy ... with positive lymph nodes could be suitable to ... Oncology (ASTRO) guidelines place these patients in the ... at the 2014 ASTRO meeting, Beaumont Health System,s ...
(Date:9/17/2014)... COLUMBIA, Md. (PRWEB) September 17, 2014 ... Nexera-e Comprehensive Two-Dimensional Liquid Chromatograph (2D-LC), which ... most complex sample matrices. The system provides ... of sample analytes, which is beneficial to ... food extracts, and natural products. , Comprehensive ...
(Date:9/17/2014)... 17, 2014 Immunomic Therapeutics, Inc. announced ... (SBIR) grant to support the continued preclinical development of ... with approximately $255,000 over one year to conduct vaccine ... food allergy, affect over one million Americans and are ... Tree nut exposure is also a risk for peanut ...
(Date:9/17/2014)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), ... technologies and products for advanced microarray diagnostics, today announced ... in the United States on ... on September 17, 2014 on the OTCQX under the ... the TSX Venture Exchange under its existing symbol SQD. ...
Breaking Biology Technology:Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 2Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 3Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 4Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3
... is the 11th in a series of articles on developing ... , Madison, Wis. - You've started your ... perhaps through investors. If you still need additional funding, what ... are basic financial principles to consider. , ,Most of ...
... Web-software services provider Zywave Inc. recently announced it ... being constructed in the Milwaukee County Research Park . ... real estate development circles, but the news is more than ... playing out, and an example of how a powerful business ...
... surging trend that has taken corporate boardrooms by ... pressure from myriad interest groups around the world ... and reporting. In 2005, according to Professor Michael ... CSR-related shareholder resolutions were filed on issues ranging ...
Cached Biology Technology:Early Stage: Step 11 - Other forms of finance 2Early Stage: Step 11 - Other forms of finance 3Early Stage: Step 11 - Other forms of finance 4Corporate venturing can nurture software success 2Corporate venturing can nurture software success 3Corporate venturing can nurture software success 4Corporate venturing can nurture software success 5Corporate venturing can nurture software success 6Corporate Social Responsibility - Burden, sham, or golden opportunity? 2Corporate Social Responsibility - Burden, sham, or golden opportunity? 3Corporate Social Responsibility - Burden, sham, or golden opportunity? 4Corporate Social Responsibility - Burden, sham, or golden opportunity? 5Corporate Social Responsibility - Burden, sham, or golden opportunity? 6Corporate Social Responsibility - Burden, sham, or golden opportunity? 7
(Date:9/17/2014)... Arts and Humanities has received a $260,000 grant from ... "The Boundaries of the Human in the Age of ... wide-ranging series of events aimed at exploring two compelling ... and researchers who are exploring the boundaries of our ... and the other involves the increasingly influential hypothesis that ...
(Date:9/17/2014)... "Nature has developed, very cleverly, some lessons on how ... design," said Joseph Shaw, director of the Optical Technology ... and structures at the nanoscale, we,ll discover them." , ... in August during a conference called "The Nature of ... Liang of the University of Arizona College of Optical ...
(Date:9/17/2014)... researchers have obtained the first partial genome sequence of ... found at the site of the Montsoriu Castle in ... is closely related to today,s Iberian pig. Researchers also ... modern Iberian pigs. , The study, published in ... pig species, and particularly on that of the Iberian ...
Breaking Biology News(10 mins):Mellon Foundation awards grant for major project in the humanities and sciences 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Iberian pig genome remains unchanged after 5 centuries 2
... This release is available in Spanish . The ... Hesprides, will set out from Cdiz on Tuesday 15th November. The ... Council (CSIC) which aims to gauge the impact of global change ... off, which will take place at 11 a.m. on the east ...
... health professionals search for ways to combat the rise in ... own eating habits and whether she views her child ... whether her child consumes enough fruits and vegetables. ... College of Nursing looked at nearly 400 low-income women (black ...
... State University biologist Kenro Kusumi,s life in 1980 when, as ... his field notebook that he had found an Anolis egg ... with other memorabilia that document the influence that both his ... current pursuits in developmental biology. One such souvenir is a ...
Cached Biology News:Malaspina 2010, the biggest ever expedition on global change, sets sail 2Malaspina 2010, the biggest ever expedition on global change, sets sail 3Malaspina 2010, the biggest ever expedition on global change, sets sail 4Mothers' diets have biggest influence on children eating healthy 21 tale told is 2 tails gained 21 tale told is 2 tails gained 31 tale told is 2 tails gained 4
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Biology Products: